In OTC Tests, Naloxone Absorption Slowed When Administered After Subjects Had Used Masks
Harm Reduction Therapeutic Among Nonprofits Backing Affordable Drugs Bill
Testing results for subjects who wore face masks before and after intranasal administration suggest early absorption of naloxone was adversely affected. Expanding Access to Affordable Prescription Drugs and Medical Devices Act would provide support for nonprofits such as Harm Reduction Therapeutics, which continues research for an NDA for an OTC naloxone nasal spray.
